Understanding Your OCT Scan and Visual Field Test Results
What an OCT Scan Measures for Glaucoma
If you have been diagnosed with glaucoma or are being monitored as a glaucoma suspect, your eye doctor likely orders two key tests at regular intervals: optical coherence tomography (OCT) and visual field testing. These tests provide different but complementary views of how glaucoma may be affecting your eyes, and understanding your results can help you feel more informed and engaged in your care. At Greenwich Ophthalmology Associates, our glaucoma specialists use advanced OCT and visual field technology to detect even subtle changes early, giving patients across the greater NY/CT region a clear picture of their eye health over time.
OCT is a non-invasive imaging test that captures detailed cross-sectional images of the structures inside your eye. For glaucoma evaluation, it focuses on two critical areas that are among the first to show damage.
The retinal nerve fiber layer (RNFL) is the layer of nerve cell fibers that carry visual signals from the retina to the brain through the optic nerve. In glaucoma, elevated or fluctuating eye pressure gradually damages these fibers, causing them to thin over time. OCT measures the thickness of this layer in microns around the optic nerve head, providing a precise numerical value that can be compared to age-matched normal ranges. A thinner-than-expected RNFL is one of the earliest structural signs of glaucoma, sometimes appearing years before you notice any vision changes.
The optic nerve head, also called the optic disc, is the circular area at the back of the eye where nerve fibers exit toward the brain. The center of the disc contains a natural depression called the cup. As glaucoma damages nerve fibers, the cup enlarges relative to the overall disc, increasing the cup-to-disc ratio. OCT provides objective measurements of this ratio along with three-dimensional mapping of the optic nerve head, helping our glaucoma specialists identify structural changes that may not be visible during a standard examination alone.
In addition to the RNFL, modern OCT devices measure the ganglion cell-inner plexiform layer (GCIPL) in the macula, the central area of the retina responsible for detailed vision. Ganglion cells are the neurons that form the optic nerve, and thinning of this layer in specific patterns can confirm or support a glaucoma diagnosis. This measurement is particularly useful when RNFL results are borderline or when other conditions make RNFL interpretation more complex.
How to Read the Color Maps on Your OCT Report
Your OCT printout contains color-coded maps and charts that may look complicated at first glance. Once you understand the color system, these reports become much easier to interpret.
Most OCT devices use a universal color classification system based on statistical comparisons to a normative database of healthy eyes. Green indicates that a measurement falls within the normal range, meaning it is similar to what would be expected for someone your age. Yellow signals a borderline measurement that falls below the fifth percentile of normal, meaning only about five percent of healthy eyes would have a value this low. Red flags a measurement below the first percentile, indicating a high likelihood of abnormal thinning that warrants close attention.
The RNFL thickness map typically displays a circular chart divided into sectors around the optic nerve, often labeled as superior, inferior, nasal, and temporal quadrants. In healthy eyes, the superior and inferior sectors are normally the thickest. Glaucoma tends to affect these thicker regions first, so red or yellow in the superior or inferior sectors is a common early finding. The report also includes an RNFL thickness profile graph that plots your measurements against a green band representing the normal range, making it easy to see where your values fall.
Your OCT report often includes a comparison between your right and left eyes. Significant asymmetry between the two eyes can be an important clue, since glaucoma frequently progresses at different rates in each eye. The report may also show trend analysis if you have had previous OCT scans, displaying whether your measurements are stable or declining over time. This trending data is one of the most valuable features of OCT for long-term glaucoma management.
What a Visual Field Test Shows
While OCT reveals structural changes in the eye, a visual field test measures how well your vision actually functions across your entire field of view. Together, these two tests give our glaucoma specialists both anatomical and functional information.
During a visual field test, also called perimetry, you sit in front of a bowl-shaped instrument and focus on a central target. Small lights of varying brightness flash at different locations in your peripheral and central vision, and you press a button each time you see one. The test maps which areas of your visual field are responding normally and which may have reduced sensitivity. It is painless and typically takes about five to seven minutes per eye, though it does require concentration.
Your visual field printout includes a grayscale image of your results. Darker areas on the grayscale map represent regions where your sensitivity to light is reduced, while lighter areas indicate normal sensitivity. In glaucoma, characteristic patterns of vision loss tend to appear, such as arcuate (arc-shaped) defects that follow the path of nerve fibers from the optic nerve. These patterns help distinguish glaucoma-related loss from other causes of visual field changes.
Below the grayscale image, you will typically see two probability plots. The total deviation plot shows how your results at each test point compare to age-matched normal values. The pattern deviation plot adjusts for any overall reduction in sensitivity, such as from a cataract, to isolate localized defects that are more characteristic of glaucoma. Points marked with darker symbols on these plots indicate areas of statistically significant vision loss.
What the Numbers on a Visual Field Printout Mean
Several numerical indices on your visual field report summarize the overall quality and results of the test. Understanding these numbers helps you have more productive conversations with your eye care team about your glaucoma status.
Mean deviation (MD) is a single number that reflects the average sensitivity of your entire visual field compared to a healthy, age-matched eye. A value close to zero indicates a normal field, while increasingly negative values represent greater overall vision loss. For example, an MD of negative two may be within normal limits, while an MD of negative ten suggests moderate field loss. Our glaucoma specialists track this number over time to determine whether your visual field is stable or declining.
Pattern standard deviation (PSD) measures how unevenly sensitivity is distributed across your visual field. A low PSD means your field is relatively uniform, whether normal or uniformly reduced. A high PSD suggests localized areas of loss with other areas remaining intact, which is the typical pattern in early to moderate glaucoma. This value is especially helpful for detecting early glaucoma damage before the overall MD becomes significantly abnormal.
The visual field index (VFI) expresses your overall visual field health as a percentage, with 100 percent representing a completely normal field and zero percent representing a fully extinguished field. Because VFI is weighted to emphasize central vision, it provides a clinically meaningful summary of functional vision. Tracking VFI over multiple tests allows your doctor to estimate the rate of progression and predict future visual function if the current trend continues.
The glaucoma hemifield test (GHT) compares corresponding sectors in the upper and lower halves of your visual field. Because glaucoma typically affects the upper and lower halves asymmetrically, the GHT is a sensitive screening tool. Results are reported as 'within normal limits,' 'borderline,' or 'outside normal limits.' An 'outside normal limits' result is strongly suggestive of glaucomatous damage and prompts further evaluation.
Frequently Asked Questions
The testing schedule depends on your risk level and disease stage. Patients who are newly diagnosed or showing signs of progression may need both tests every three to four months to establish a reliable baseline and detect changes quickly. Those with stable glaucoma on effective treatment often move to testing every six to twelve months. Your doctor will adjust the frequency based on your individual trend data and eye pressure readings.
Thinning on OCT does not automatically mean you are losing vision, but it does signal that structural damage may be occurring. Some people have naturally thinner nerve fiber layers without having glaucoma, which is why your doctor interprets OCT findings in the context of your complete clinical picture, including your visual field results, eye pressure history, and family history. Progressive thinning over multiple scans is more concerning than a single borderline measurement.
Yes, and this is one of the most important advantages of OCT in modern glaucoma care. Research has shown that measurable structural thinning on OCT can precede detectable visual field loss by several years. This is because a significant percentage of nerve fibers can be lost before the standard visual field test picks up functional changes. Catching these early structural signs allows treatment to begin sooner, which can help preserve vision long-term.
Your visual field printout includes several reliability markers that indicate how accurately you performed the test. Fixation losses measure how often your gaze wandered from the central target. False positives indicate responses when no light was actually shown, and false negatives indicate missed responses to bright stimuli you would normally see. High rates of any of these suggest the test results may not fully reflect your true visual field, and your doctor may recommend repeating the test for a more accurate reading.
Our glaucoma specialists rely on trend analysis, which involves comparing your results from multiple tests over time rather than focusing on any single visit. Software built into OCT and visual field devices calculates rates of change and highlights whether thinning or field loss is occurring faster than expected. This approach accounts for normal variability between tests and provides a more reliable assessment. If progression is confirmed, your treatment plan may be adjusted to achieve a lower target pressure and slow future changes.
A single worsening result does not necessarily mean your glaucoma is advancing, as factors like fatigue, dry eyes, or a learning curve with the visual field test can influence outcomes. However, if a trend of worsening is confirmed across multiple visits, it is important to discuss treatment options with your doctor promptly. Adjustments might include changing or adding eye drop medications, considering laser treatment, or exploring surgical options. Patients in higher-risk groups may benefit from more frequent monitoring to catch progression as early as possible.
Take the Next Step for Your Glaucoma Care
Understanding your OCT and visual field results is an important part of being an active participant in your glaucoma care. At Greenwich Ophthalmology Associates, our fellowship-trained glaucoma specialists combine advanced diagnostic imaging with decades of clinical experience to help patients across the greater NY/CT region protect their vision for the long term. If you have questions about your latest test results or would like to schedule a comprehensive glaucoma evaluation, we welcome the opportunity to guide you through every step of your care.
We encourage you to bring your questions and concerns to your next appointment so we can develop a care plan that addresses your goals and lifestyle.
Learn More About Related Topics
To further your understanding, explore our resources on Visual Field Testing for Glaucoma and Other Diseases, Glaucoma Meaning: Understanding the Silent Thief, and Is Glaucoma Hereditary? Understanding Your Family Risk.
You may also find these pages helpful: Will I Go Blind from Glaucoma? Understanding Your Prognosis, Angle-Closure Glaucoma: Recognizing the Emergency, and Angle-Closure Glaucoma: Symptoms & Emergency Treatment.
What our Patients say
4.8
Reviews
(3645)